Jushi Holdings Inc.·Healthcare

Jushi Holdings Inc. (JUSHF) Q4 2025 Earnings Call Transcript

Jushi Holdings Inc. (JUSHF) came out with a quarterly loss of $0.08 per share versus the Zacks Consensus Estimate of a loss of $0.06. This compares to a loss of $0.06 per share a year ago.

Revenue of $262.9 Million for Full Year 2025, Up 2% Year-Over-Year, Reflecting Contributions from New Store Openings

The cannabis industry is bringing much more attention to itself with every progressive step. Legal cannabis worldwide is becoming more accepted and treated like any other legitimate industry. This also brought in people looking to get involved in the sector. For most, this comes in the form of finding the best marijuana stocks to buy. However, if you are new to cannabis investing, there are steps that need to happen. First, you need to learn about pot stocks and which cannabis companies are publicly traded and dominating the industry.

Jushi (OTCMKTS:JUSHF - Get Free Report) and Brainsway (NASDAQ: BWAY - Get Free Report) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their dividends, risk, profitability, institutional ownership, earnings, analyst recommendations and valuation. Institutional and Insider Ownership 21.7% of Jushi shares are

Adds Cash to the Balance Sheet The Company to Report Fourth Quarter 2025 Financial Results on March 31, 2026 BOCA RATON, Fla., March 27, 2026 (GLOBE NEWSWIRE) -- Jushi Holdings Inc. (“Jushi” or the “Company”) (CSE: JUSH ) (OTCQX: JUSHF ), a vertically integrated, multi-state cannabis operator, announced that it has completed the refinancing (the “Refinancing”) of its former senior secured credit facility (the “Former 1st Lien Credit Facility”) and its former second lien credit facility (the “Former 2nd Lien Credit Facility”) through the issuance of a $160 million senior secured term loan (the “Term Loan”) with funds managed by FocusGrowth Asset Management, along with other members of a loan syndicate.
Jushi Holdings Inc., a vertically integrated cannabis company, engages in the cultivation, processing, retail, and distribution of medical and adult-use products. It focuses on building a portfolio of cannabis assets in various jurisdictions in Pennsylvania, Virginia, Ohio, Illinois, California, Nevada, and Massachusetts. The company also offers hemp-based CBD products, including cannabidiol supplements, tinctures, capsules, softgels, and topicals under The Bank, The Lab, Nira+ Medicinals, Seche, Tasteology, and Nira brands. As of June 6, 2022, it operated 33 BEYOND/HELLO retail locations. The company was incorporated in 2007 and is headquartered in Boca Raton, Florida.
Healthcare
Drug Manufacturers - Specialty & Generic
1,234
2019-06-18
0.99